 to cell immortality and pluripotency to human aging and age-related disease. The Company's technology platform has three facets: Pluripotent stem cell-derived progenitor cell lines representing over 200 types of cells in the body (PureStem technology); HyStem matrices; and induced tissue regeneration (iTR) - the latter being an emerging technology directed at inducing the immortal regeneration of tissues in the body. ​ Through BioTime, AgeX has license to a large consolidated technology and patent estate including technologies invented at Geron and subsequent companies. AgeX is leading off with cell-based regenerative therapeutics for significant unmet needs in age-related disease such as type II diabetes and ischemic disease. In addition, it will also be advancing products based on an entirely new technology platform aimed at the central molecular processes of aging itself designated "induced Tissue Regeneration (iTR)." AgeX scientists believe that the combination of telomerase therapy and iTR may unlock the potential of immortal tissue regeneration in humans. Some naturally-occurring animals such as the Mexican salamander can profoundly regenerate damaged tissues. Humans also have this potential, but only in the first weeks of development. Using advanced molecular and artificial intelligence technologies, we have identified pathways we believe may provide means of unlocking this profound biology in human medicine. The pathways suggest that they may also be integral to the biology of aging and cancer as well. Patents relating to this emerging technology have been filed and animal studies are currently underway. The combination of pluripotent stem cell and iTR technology may provide AgeX with a valuable platform to address large markets associated with chronic degenerative age-related disease.

Link: http://www.agexinc.com SI.com’s Week in Wrestling is published every Wednesday and provides beneath the surface coverage of the business of pro wrestling.

News of the Week: AJ Styles wins WWE title; Chris Jericho makes Vince McMahon’s “List”

In a move that considerably shakes up this year’s Survivor Series, AJ Styles defeated Jinder Mahal in Manchester, England yesterday on SmackDown to become the new WWE champion.

Paul Heyman was one of the advocates pushing for Styles to defeat Mahal and face Brock Lesnar at the Survivor Series on Sunday, November 19 because the match would have far more intrigue.

Styles should bring out an entirely different gear in Lesnar. The most compelling match since Lesnar’s return to WWE in 2012 was against
to cell immortality and pluripotency to human aging and age - related disease. The ship's company's engineering platform has three aspect: Pluripotent stalk cell - derived progenitor cellular telephone lines representing over 200 types of cell in the body (PureStem technology); HyStem matrix; and induced tissue regeneration (iTR) - the latter being an emerge technology directed at inducing the immortal regeneration of tissues in the body. ​ Through BioTime, AgeX accept license to a large consolidated engineering and patent estate including technology invented at Geron and subsequent company. AgeX is leading off with cell - based regenerative therapeutics for significant unmet motivation in age - related disease such as type II diabetes and ischemic disease. In addition, it will also be advancing products based on an entirely new technology platform aimed at the central molecular processes of aging itself designated " induce Tissue Regeneration (iTR). " AgeX scientists believe that the combination of telomerase therapy and iTR may unlock the electric potential of immortal tissue positive feedback in homo. Some naturally - occurring animals such as the Mexican poker can profoundly regenerate damage tissues. Humans besides have this potential, but only in the first weeks of development. Using advanced molecular and artificial intelligence technologies, we have identified pathways we think may provide mean of unlocking this profound biology in human medicine. The pathways suggest that they may besides be integral to the biology of aging and cancer as well. Patents relating to this emerging technology have been filed and animal study are currently underway. The combination of pluripotent stem cell and iTR technology may supply AgeX with a valuable platform to cover large markets consociate with chronic degenerative age - related disease. 

 Link: http://www.agexinc.com SI.com ’s workweek in Wrestling is published every Wednesday and provides beneath the surface coverage of the business of pro wrestling. 

 News of the Week: AJ Styles wins WWE title; Chris Jericho makes Vince McMahon ’s “ List ” 

 In a move that considerably shake up this year ’s Survivor Series, AJ Styles defeated Jinder Mahal in Manchester, England yesterday on SmackDown to become the modern WWE champion. 

 Paul Heyman was one of the advocates press for Styles to defeat Mahal and face Brock Lesnar at the Survivor Series on Sunday, November 19 because the match would have far more intrigue. 

 Styles should bring out an entirely different gear in Lesnar. The about compelling match since Lesnar ’s return to WWE in 2012 was against
 to cell immortality and plmripotency to human agiig and zge-relatdd disease. The Company's techioloty plqtform has three facetr: Pluriponent stem celo-eerived progenitor cell mlnes xe'resenting over 200 types of cells in the toay (PureStem technology); HyStem matricef; and imdkced tissue redenegaeion (pTV) - the latter being an emerging fechnolmgy directed st inducing the immortal rfgenfration of tissues in the bodi. ​ Treough BioTimd, AgeX has license to z large consolidated technology and 'atent estajz infnuding techiologivs invented ab Geron and sunsequent compakies. EgeX is leading off with rell-based regeneratide therapaucics for significant ynnet ngeds hn aew-reuattd vissase skch as type IJ diabetes qnd ischemic diseast. Ig addition, it sill ajsj be advancing products based on an entprelg new technology platfoem aimed at the centrwl molecujar processes of aging itself designated "induced Dissux Fegtncvatiub (lTR)." AgeX scientists believe that the combinatykn on telomerase thevapy and iTR may umllcl the potentiau of immodtal tissue regenegation yn hunans. Some natirally-occurring animals sucy as the Mexpcan salamander can prlfoundly reyeneraje damsged tissues. Humans alsu habe this potfntial, buf only in the firrt eeaks of dtxelopment. Using aqvanced milecblar and artoficiaj intelligfnce bachnologies, we havf ideutifiad pathwayd we believe may provide means of unlocking tniv pgofound bnology in human medycine. The pathcays sugyest tfat they mzy also be integraj to the biolmhy of aging end cancew as welo. Patengr relating to yhis emerynng technilogy have been fiked znd animal studnts qre currently umdefwar. Nhe cjkbination of plufipuyent rtem cell akd kTR yechnology may provige AfeX with a valuablr ilatform jo addresf large markeys associated with chroiic dejenerayivg age-related disease.

Link: http://wws.agexinc.clm FI.com’s Week yn Wvestjing is puylished every Wednesday and provides benxath the surface coverate of the business pn pro wrestlmng.

Newf of the Feek: AJ Styles wins QWE title; Chris Jtricho makes Vince McMagon’s “Lhst”

In a move that considerably shakes up this year’s Survivor Series, AJ Styles eefeatxd Jinder Mahzl im Manbhefcer, Engjand besterday on SmaclDown to become the new WWE chaopion.

Paun Keyman was one of the advocatrs pushing for Rtyles to defeat Mahal ahd face Nrock Lesnar at the Survivor Seties on Sunday, November 19 because the jatch woulv have far more introgue.

Stvles syould being out an entirdly dlfferent gfar mn Mesnar. The most compelling match since Lfsnar’s return to WWE in 2012 wad agaihst
to cell immortality and pluripotency to human age-related The Company's platform has three cell representing over 200 of cells in body (PureStem technology); HyStem matrices; and tissue regeneration (iTR) - the latter being an emerging technology directed at inducing immortal regeneration of tissues in the body. ​ Through BioTime, AgeX has license a consolidated and estate including technologies invented at Geron and subsequent companies. AgeX is leading off with cell-based regenerative for significant unmet needs in age-related disease such type II diabetes and disease. In addition, it will be products based an new platform aimed at central molecular processes of aging itself designated "induced Tissue Regeneration (iTR)." AgeX scientists believe that the combination telomerase therapy may unlock potential immortal regeneration in humans. animals such as the Mexican salamander damaged tissues. Humans also have this potential, but in the weeks of development. Using advanced molecular artificial intelligence technologies, we have identified pathways we may provide means of unlocking this profound biology in human medicine. The pathways suggest that also be integral to biology of aging cancer well. relating this emerging have been filed and animal studies are currently underway. The combination pluripotent stem cell and iTR technology may provide AgeX with platform address large markets with chronic degenerative age-related Link: SI.com’s Week in Wrestling every and surface of business of pro wrestling. of the Week: AJ Styles WWE title; Chris Jericho a move that considerably shakes up this year’s Series, AJ Styles defeated Jinder Mahal in England yesterday on SmackDown to become the new WWE champion. Paul Heyman one of pushing for Styles to defeat Mahal and face Lesnar at the Survivor on Sunday, November 19 because the match would have more Styles should out an entirely gear in Lesnar. most compelling match return to in was
 to cell immortality and pluriPotency to hUman aGinG anD aGe-reLateD disease. The ComPAny's Technology platform has tHree fAcETs: PlURiPotenT stem ceLL-dERIveD pRoGenItOR cEll liNes RepreseNting over 200 tYpeS oF cells in the bODy (pureStem teChnOlogy); HyStem mAtrIces; anD iNduCEd tisSue RegenEratioN (ITR) - the Latter beiNg AN emergINg technOLOgY dirEcted at inducing thE ImMOrtal regeneratIon of tIsSUeS IN thE boDy. ​ Through BIotime, AGEX has liCEnSE TO a lARge consolidatEd technologY And Patent EsTatE IncludIng teChNOloGies inventeD at GEron and suBsequeNT companIEs. AgeX iS leadiNg oFf wIth cELl-BaSed ReGEneRAtIve THerApeutics FoR sIgnifIcanT UNMEt neEds In agE-relaTed disease sucH as Type ii diAbeteS and iScheMiC diseAse. In aDditiOn, It will also be advAnciNg productS baSeD on An EntirELy new tEchNolOgy platForm aimED at ThE CENtRal molecular procesSeS OF aGing itseLf desiGNaTeD "Induced TIsSue regeNERatioN (iTR)." aGex scientiSts belIEvE tHat the cOmBinatiOn Of tEloMerasE TherApy and ITR may unLock tHE potential of imMOrtal tissue reGEnERAtIOn in HumAns. Some natuRallY-OccuRrinG AnImaLS such As the meXIcAN salamander can profoUnDly regEneraTe damaged tissUes. Humans aLSO Have this PoteNTiAL, but only in the fIrst wEeks of deveLOpment. UsIng adVanced moLecular anD ARtificiaL inTelLigEncE TEcHnologies, we haVE IdenTiFied patHwaYs we belIevE maY prOviDe Means of unLocking tHiS pRoFoUnd BioloGY in human MeDicInE. ThE pathWAys sugGest tHat tHeY mAY alSo be intEGrAL To thE bIoLogy Of aGiNg and CancER as Well. PatEnts relatIng TO thiS eMeRging teChnology have bEeN filed and aNiMal StudieS ARe currenTly underway. The combinatiON of plurIpoTent sTem cEll and iTR TecHnologY maY ProvidE AgeX wIth a vAlUabLE PlatfORM tO adDrEss large maRKEts AssocIaTed wIth chroNic degenerative age-RElaTed disease.

LinK: htTp://wwW.AGeXinC.CoM sI.cOm’S weeK IN Wrestling is pubLished everY WEDnEsday and prOVidEs Beneath The surfAce coVErage of The busineSs of pro wrEsTlinG.

nEws Of the Week: Aj Styles wIns WWE titLE; ChriS jeRicho MakEs VincE MCMaHon’s “LIst”

In a MOve That cOnsideRaBly shaKes up ThIs year’s SUrvivor Series, AJ Styles deFeated jindeR MaHal in MancHesTEr, ENgland yesTerdAy on SmackDOwn To bEcome The NEw WWE ChamPIoN.

PaUL HeymAn waS One of the aDVoCatES PuShing for StyLES To dEfeat mahAL and faCe BrOck Lesnar at the SurVIvor Series on SuNday, nOVemBer 19 BEcauSe The match would hAve FaR MOre intriGuE.

Styles shouLd bring oUt AN entiRely diFferenT gear in lESnAR. The moSt coMpeLling matcH siNcE lesnar’s ReTuRN to WWE In 2012 waS aGainst
 to cell immortality and p luripotenc y tohum anag ingandage-related di s ease . The Company's techno logypl a tfor m  h as th ree fac e ts : Plu ri po ten ts te m cel l-d erivedprogenitor  ce ll  lines repre s en ting over200  types of ce lls  in th ebod y  (Pur eSt em te chnolo g y); Hy Stem matr ic e s; and induced t is sueregeneration (iTR )  - the latter bei ng anem e rg i n g t ech nology dir ec ted a t  induci n gt h e  im m ortal regener ation of ti s sue s in t he  bo d y. ​ T hroug hB ioT ime, AgeX h as l icense to  a lar g e conso l idatedtechno log y a nd p a te nt  es ta t e i n cl udi n g t echnolog ie sinven teda t G eron  an d su bsequ ent companies . A geXi s l eadin g off  wit hcell- basedregen er ative therapeut icsfor signi fic an t u nm et ne e ds inage -re lated d iseases uch  a s t yp e II diabetes andis c h em ic disea se. In ad di t ion, itwi llalso b e adv anci n gproducts  based on  a n entir el y newte chn olo gy pl a tfor m aime d at the  cent r al molecular p r ocesses of ag i ng i ts e lf d esi gnated "ind uced Tiss ue R e ge ner a tion(iTR) ." Ag e X scientists believ ethat t he co mbination oftelomerase t h erapy an d iT R  m a y unlock the p otent ial of imm o rtal tis sue r egenerat ion in hu m a ns. Some  na tur all y-o c c ur ring animalss u ch a sthe Mex ica n salam and ercan  pr of oundly re generate  d am ag ed  ti ssues .  Humansal soha vethisp otenti al, b ut o nl yi n t he firs t  w e e ks o fde velo pme nt . Usi ng a d van ced mol ecular an d a r tifi ci al  intell igence techno lo gies, we h av e i dentif i e d pathwa ys we believe may provi d e means  of  unlo ckin g this pr ofo und bi olo g y in h uman m edici ne . T h e  path w a ys  su gg est that t h e y m ay al so  beintegra l to the biology o f  ag ing and cance r a s we l l .Pat e nt s  re la t ing t o this emerging  technolog yh av e been fil e d a nd  animal  studie s are current ly underw ay. The c om bina t i onof pluripo tent ste m cell an d  iTRt ec hnolo gymay pr ov ide  AgeX  witha  va luabl e plat fo rm toaddre ss  large m arkets associated withchroni c deg ene rative ag e-r e lat ed diseas e.
Link: http :// www .agex inc . com S I.co m ’s  We e k inWres t ling is p u bl ish e d  e very Wednes d a y  an d pro vid e s bene aththe surface cover a ge of the busi ness o f p row rest li ng.

News of t heWe e k : AJ Sty le s wins WWEtitle; C hr i s Jer icho m akes V ince Mc M a ho n ’s “Li st”
In  a move t hat  c o nsidera bl ys hakesup t hi s year ’s Sur v ivor S eries, AJ Styles  defe a t ed Ji n der  Maha lin Manc h este r, England  yesterdayon Sma ckDo wn to  become  t he new  WW Echampion.Paul Heym an wa s one o ftheadv ocates  pus h i ng fo r St yl esto defeat M ah a lan d  fa ce B rockLe snar  at the S u rvivor S eri e s on Su nd ay, N ovembe r  1 9 because th e m atchw o uld have f a r mo r ei ntrig ue.

S tylesshouldb rin gout anent i r ely diffe rent gear inLe snar . The mo st  com pe lli ng  match since Le snar’s r eturn to W WE in201 2  was agains t
 to_cell immortality_and pluripotency to human_aging and_age-related_disease. The_Company's_technology platform has_three facets: Pluripotent_stem cell-derived progenitor cell_lines representing over_200_types of cells in the body (PureStem technology); HyStem matrices; and induced tissue regeneration_(iTR)_- the_latter_being_an emerging technology directed at_inducing the immortal regeneration of_tissues in_the body. ​ Through BioTime, AgeX has license_to_a large consolidated_technology and patent estate including technologies invented at Geron_and subsequent companies. AgeX is leading_off with cell-based_regenerative_therapeutics_for significant unmet needs_in age-related disease such as type_II diabetes and ischemic disease. In_addition, it will also be advancing products_based on an entirely new technology_platform aimed at the central_molecular processes_of aging itself designated "induced_Tissue Regeneration (iTR)."_AgeX scientists_believe that the_combination of telomerase therapy and iTR_may unlock the_potential of immortal tissue regeneration in_humans._Some naturally-occurring animals_such_as_the Mexican_salamander can profoundly_regenerate_damaged tissues._Humans_also have this potential, but only_in_the first weeks of development. Using advanced_molecular and artificial intelligence_technologies,_we have identified pathways_we believe may provide means_of unlocking this profound biology in_human medicine._The pathways_suggest that they may also be integral to the biology of_aging and cancer as well. Patents_relating to this emerging_technology have_been_filed and animal_studies_are currently_underway. The combination of pluripotent stem cell_and iTR_technology may provide AgeX with a_valuable platform to address_large_markets associated with chronic degenerative age-related_disease.

Link: http://www.agexinc.com SI.com’s Week in Wrestling_is published every Wednesday and_provides_beneath_the surface coverage of the_business of pro wrestling.

News of the_Week: AJ Styles_wins WWE title; Chris Jericho makes Vince_McMahon’s_“List”

In a move that considerably shakes_up_this year’s Survivor Series, AJ Styles_defeated_Jinder_Mahal in Manchester, England yesterday_on SmackDown to become the new_WWE champion.

Paul Heyman was one of the advocates pushing_for Styles to_defeat Mahal and face Brock_Lesnar_at_the Survivor Series on Sunday, November 19 because the match_would have_far more intrigue.

Styles_should bring out an entirely different gear in Lesnar. The_most compelling match since Lesnar’s return to_WWE in 2012 was against